Adjuvant therapy of renal cell carcinoma with active-specific-immunotherapy (ASI) using hutologous tumor vaccine

Anticancer Research

Volumn 17, Issue 4 B, 1997, Pages 2879-2882

  Repmann, R ^a   Wagner, S ^a   Richter, A ^a  

^a Klinikum St Georg   (Germany)

Author keywords

Active specific immunotherapy (ASI); Autologous tumor cells; Renal cell carcinoma (RCC); Tumor vaccine

Indexed keywords

TUMOR VACCINE;

ADJUVANT CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER STAGING; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME;

CANCER VACCINES; CARCINOMA, RENAL CELL; HUMANS; IMMUNOTHERAPY, ACTIVE; KIDNEY NEOPLASMS; SURVIVAL RATE;

EID: 0030880837     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (11)

1. Hermanek P, Schrott KM: Evaluation of the new tumor, nodes and metastases classification of renal carcinoma. J Urol 144: 238-242, 1990.
2. Huland H: Nierenzellkarzinom In: Therapie urologischer Tumoren, (Ackermann et al., eds.), Karger, Munchen, 1990, 25-39
3. Yagoda A: Chemotherapy of renal cell carcinoma: 1983-1989. Sem Urol 7: 199-206, 1989.
4. deRiese W, Goldenberg K, Alhoff E, Stief C, Schlick R, Liedke S, Jonas U: Metastatic renal cell carcinoma (RCC): spontaneous regression, long-term survival and late recurrence. Int Urol Nephrol 23: 13-25, 1991.
5. Kriegmair M, Oberneder R: Die Tumorzellvakzinierung zur Behandlung des Nierenzellkarzinoms. Urologe A 34(3), 204-207, 1995.
6. Dillman RO, Nayak SK, Beutel L: Establishing in vitro cultures of autologous tumor cells for use in active specific immunotherapy. J Immunother 14 (1), 65-69, 1993.
7. Pomer S, Thiele R, Staehler G, Drehmer 1, Lohrke H, Schirrmacher V: Tumor vaccination in renal cell carcinoma with an without interleukin-2 (IL-2) as adjuvant. A clinical contribution to the development of effective active specific immunization. Urologe A 34(3), 215-220, 1995.
8. Galligioni E, Francini M, Quaia M, Carbone A, Spada A, Sacco C, Favaro D, Santarosa M, Carmignani G, Di Donna D et al: Randomized study of adjuvant immunotherapy with autologous tumor cells and BCG in renal cancer. Ann N Y Acad Sci 690: 367-369, 1993.
9. Tallberg T, Tykka H: Specific active immunotherapy in advanced renal cell carcinoma: A clinical longterm follow-up study. World J Urol 3: 234-244, 1986.
10. Heicappell R, Ackermann R: Rationale for immunotherapy of renal cell carcinoma. Urol Res 18: 357-372,1990.
11. Robson CJ, Churchill BM, Anderson W: The results of radical nephrectomy for renal cell carcinoma. J Urol 101: 297-301, 1969.